chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After my J&J vaccine at night I experienced fever, chills and body aches. The next day when I woke up I felt a lump on my neck. I went to ER on 04-09-2021 where they examined my neck and they told me that my lymph nodes are swollen and the ER doctor told me that that was a reaction to my vaccine and that it would go away in a few days. I can say that before the vaccine I did not have my lymph nodes enlarged. To this day I still feel the lump on my neck. The ER doctor did not give me any medications.
Noted redness and swelling in left upper arm on 03-08-2021. Slight itching. Today, less redness and less swellimg
Significant joint pain, lasting all day. Mostly in knees and hips. It has been consistent for 2 weeks. There were no symptoms prior to vaccination.
She's exhibit pain; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a 77-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 24th June 2022, the patient received Shingles vaccine. In June 2022, less than a week after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 25-JUN-2022 Reporter's Comments: This case was received from patient's mate via interactive digital media. The reporter stated that the patient yesterday receive the Shingles vaccine and she had exhibit pain. What should he/she should do. Additional Supportive Information: The follow-up would not possible as no contact details were available.
This case was reported by a consumer via out of hour services and described the occurrence of shingles in a male patient who received SHINGRIX for prophylaxis. On 29th August 2018, the patient received SHINGRIX. On 4th September 2018, 6 days after receiving SHINGRIX, the patient experienced shingles and rash. On an unknown date, the outcome of the shingles and rash were unknown. It was unknown if the reporter considered the shingles and rash to be related to SHINGRIX. Additional information was reported as follows: The age at vaccination was not reported. On 4th or 5th September the patient he noticed a rash. On 12th September 2018, the patient went to the doctor where the doctor diagnosed it as shingles. The patient left some patient identifier information, on a voice message after adverse event reporting line hours. This was all the information provided. The reporter stated that, he would attempt a call back and update at time(PCP). The phone number provided by the patient would not go through as the reporter was not able to reach him for any follow-up information.
Mild body aches; Mild body aches and head ache; Soreness at injection site; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248), via an unspecified route of administration in the right arm on 22Mar2021 at 12:15 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications were not reported. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccination. The patient previously received first dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248), via an unspecified route of administration in the right arm on 01Mar2021 at 12:15 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. The Patient previously took Penicillin for unknown indication and experienced an allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 23Mar2021 at 12:00, the patient experienced mild body aches, headache and soreness at injection site. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the mild body aches, headache and vaccination site pain was recovering.   No follow-up attempts are needed. No further information is expected.
Pt came into clinic with vaccine card indicating she had already recieved her first dose of Moderna.  She was given a new vaccine card  to replace her original vaccine card because it had writing in the "second dose" line.  Pfizer was written in on new card for first dose. Pt went to Pfizer side of clinic where she was vaccinated with a Pfizer dose. Nurse went to document for patient and was unable to click administer. Nurse and pt went to registration table where it was discovered pt had recieved Moderna for her first dose on 4/13/21 and was scheduled for her second dose Moderna today.
pt became pregnant a/the scheduled 2nd dose; 2nd & 3rd doses deferred until post pregnancy;
Received pneumonia shot about noon 10/19/05 in my right arm. My arm began to hurt by 4PM that afternoon.  I could not lift my arm.  Put ice pack on the resat of the day.  Next morning, my right arm was 2-3times the size of my left arm.  It was very tender.  I called the doctor after breakfast.  I was instructed to continue with ice and take Tylenol for the pain.  I did that for the remainder of the day. I got up Friday, October 21 and my arm was hot to the touch, the swelling was from my shoulder to be;ow my elbow. My arm was red from my shoulder to my wrist.    Called the doctor once again.  Described my arm.  I was told to come in to see the doctor.  Once the doctor saw the arm, he said it was infected, celullitis.  He prescribed amoxicillin
sore arm; hot flashes have come back; This is a spontaneous report from a contactable consumer (patient). A 63-years-old female patient (Non-Pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were unknown), via an unspecified route of administration in left arm on 08Jan2021 at 10:30 as a single dose for COVID-19 immunization. The patients medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine; Prior to vaccination, was the patient was not diagnosed with COVID-19; Since the vaccination, the patient has not been tested for COVID-19. The patient experienced sore arm hot flashes have come back. No treatment was received for the event. The outcome of the event was recovered in 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
fever and sore throat; fever and sore throat; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (fever and sore throat) and PYREXIA (fever and sore throat) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010a21a) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (fever and sore throat) and PYREXIA (fever and sore throat). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, OROPHARYNGEAL PAIN (fever and sore throat) and PYREXIA (fever and sore throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications reported. No treatment information was provided.
Before and after receiving the vaccination,  I was feeling fine.  Approximately four hours after the injection, I started feeling a tightness in my chest and a slight dry cough.  I could also feel myself starting to wheeze with each breath.  As I began talking, my voice became quite hoarse until I could barely speak.  I was overcome by extreme chills and terrible headache.  I bundled myself up with layers of clothes and blankets and climbed into bed with a cup of regular tea.  Bedroom temperature was at 71 degrees and I couldn?t warm up.  Used a hand warmer for more heat. By 7 PM,, my eyes were terrible swollen, along with upper lip.  I then consumed a Benedryl capsule, which did not help tightness of Che?s.
EXCESSIVE PAIN; SEVERE HEADACHE; NAUSEA; This spontaneous report received from a patient concerned a female of unspecified age. Initial information was processed along with additional information received on 18-MAR-2021. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025, expiry: UNKNOWN) dose was not reported, administered on 08-MAR-2021 on left deltoid for prophylactic vaccination. No concomitant medications were reported. On 08-MAR-2021, the subject experienced excessive pain. On 08-MAR-2021, the subject experienced severe headache. On 08-MAR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the severe headache, excessive pain and nausea was not reported. This report was non-serious. The suspected product quality complaint has been confirmed to be voided (did not meet pqc criteria) based on the PQC evaluation/investigation performed.
Patient fainted, was pale, Vital signs stable accucheck 106. After providing juice patient fainted again. Continue observation until patient was feeling better which took an hour.
it was rpt fr HCP concerning pt who was vax & in 1998 pt exp a lack of seroconversion. addl info requested
Pt. felt light headed & weak at 01:00 on 8-8-09 - went to Hospital ER & stayed until 05:00 on 8/8/09. Low grade temp - 99.7 (o) Had IV fluids & dose of TYLENOL. She states that MD thought she had reaction to meningitis shot given at BTM on 8-7-09. To home at 05:00 on 8/8/09.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 14Oct2022 as dose 5 (booster), single (Lot number: GJ6939) at the age of 69 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 03Feb2021 as dose 1, single (Lot number: EN9581), in left arm, on 24Feb2021 as dose 2, single (Lot number: EN6198), in left arm, on 03Oct2021 as dose 3 (booster), single (Lot number: 30145BA), in left arm and on 02Apr2022 as dose 4 (booster), single (Lot number: FK9895), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Depression" (unspecified if ongoing); "Insomnia" (unspecified if ongoing); "A-fib corrected" (unspecified if ongoing); "chemo induced neuropathy" (unspecified if ongoing). The patient has no known allergies. Concomitant medication(s) included: LYRICA, start date: 01Jun2017. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jan2023, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jan2023) Positive, notes: Positive at home test; (Jan2023) Positive, notes: positive rapid test at Urgent. Therapeutic measures were taken as a result of vaccination failure, covid-19 including Paxlovid treatment on 15Jan2023 to 19Jan2023.
Patient admitted to Hospital 4/6-4/9 for bilateral lower back pain, fever, sore throat and leukocytosis. Diagnosed with a R iliofemoral nonocclusive thrombus present on admission. Ultrasound was performed and there was no evidence of an occlusive thrombus, there was evidence of flow through her previously placed stent. She was placed on a heparin drop and converted back to Xarelto at the time of discharge. Chest CT showed no evidence of PE. Of note, patient went on spring break and was out her Xarelto, missed approximate 4 days worth of medical. She was also diagnosed and treated for an acute strep throat infection.
t102 for days immed p/vax; local swelling & rxn over the rt deltoid where inj was given; full ROM
Caller stated he got Pfizer vaccine on 3/36, and later that day arm was sore, and had fatigue, but that both are gone now. He stated he started coughing the same day and is still coughing. He denies any other symptoms.    No lot number was available at this time.
"Pt w/ hx of allergy to naproxen (swelling in the face). PMH significant for HTN, hx of DTV of RUE, breast cancer, depression, obesity, pre-diabetes. Current Medications: atenolol 25mg PO Daily exemestane 25mg PO Daily gabapentin 300mg PO TID HCTZ 12.5mg PO QAM Omeprazole 20mg PO QAM 30mins before breakfast Vitamin B6 50mg PO BID with meals Simethicone 250mg PO TID PRN gassiness venlafaxine 24hr cap 75mg PO daily 10min post vaccination, pt c/o numbness of the mouth/lips and nose on the left side. Vitals: @10:30 BP 99/61, HR 66, RR 20, SpO2 97% on RA -- > @10:45 93/60, 67, 18, 97% on RA -- > @11:00 99/59, 62, 18, 98% on RA. Pt's symptoms resolved. Pt stable and released from the vaccination site."
This was my second vaccine given.  A few weeks after  I started feeling strong heart beats every once in a while (palpitations),i mostly felt them when at rest or when in bed. I've been waiting to see if they go away but it has not.
A large part of the upper left arm was slightly swollen and became very itchy for 12+ days.
no adverse effect; multiple patients were vaccinated with improperly stored VAQTA on multiple dates; This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 20-MAR-2019, the patient was vaccinated with improperly stored hepatitis a vaccine, inactivated(VAQTA) lot # R027431, expiry date 08-SEP-2019 for prophylaxis.  No adverse event was reported. Previous temperature excursion was reported. Data logger was involved.
Patient came to ED for generalized weakness and low blood pressure.  Patient was admitted to the hospital with Covid and treated with remdesivir.
At injection site: Swollen,red,hot to the touch. Large bumpy reddish rash,itchy.
Chest pressure with pain lasting 203 minutes on day 3 (3-20-03). ongoing laeft arm ache on 3-21-03.
dime-like size egg under the skin in neck, collarbone, left armpit; very sick; fever; burning in lung; sore throat; loss voice; barely could get out of bed; nauseous; headache; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nauseous), HEADACHE (headache), ILLNESS (very sick), PYREXIA (fever) and AIRWAY BURNS (burning in lung) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included TIOTROPIUM BROMIDE MONOHYDRATE (SPIRIVA) for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Aug-2021, the patient experienced NAUSEA (nauseous) and HEADACHE (headache). On 01-Sep-2021, the patient experienced ILLNESS (very sick), PYREXIA (fever), AIRWAY BURNS (burning in lung), OROPHARYNGEAL PAIN (sore throat), APHONIA (loss voice) and MOBILITY DECREASED (barely could get out of bed). On 07-Sep-2021, the patient experienced AXILLARY MASS (dime-like size egg under the skin in neck, collarbone, left armpit). On 31-Aug-2021, NAUSEA (nauseous) and HEADACHE (headache) had resolved. At the time of the report, ILLNESS (very sick), PYREXIA (fever), AIRWAY BURNS (burning in lung), OROPHARYNGEAL PAIN (sore throat), APHONIA (loss voice), MOBILITY DECREASED (barely could get out of bed) and AXILLARY MASS (dime-like size egg under the skin in neck, collarbone, left armpit) outcome was unknown.    Patient reported taking Ibuprofen for her headache.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  Treatment information not reported.
In the same night after my vaccination, I had fever, chills, heat, headache, body ache, chest pain, racing heart like 120s beat per min, shortness of breath. After taking  some herbal pills for fever and inflammation, heart rate was decreased to 110s beat per min. With another two-three rounds of herbal pills, heart rate was gradually reduced to the upper 80 beats per min. I was wearing my Fitbit watch and my Fitbit health report showed that my heart rate was in the fat burning zone for almost 24 hours when laying in bed that night. Fever was gone in a day or two but it took me a few days to start feeling my heart was better.
Nurse administered Pfizer Pediatric 0.2mL dose, second dose in series in left deltoid. Approximately 10 minutes after injection, Patient noticed bumps developing on arms bilaterally and back,  followed by itching a few moments later.  Denies any other signs or symptoms of anaphylaxis or further allergic reaction. Patient weighs approximately 90 lbs, benadryl 50mg IM was administered in Right Deltoid at 18:45, hives have improved and itchiness have subsided.  Mom and patient waited an additional 30 minutes. Instructed mother if any further symptoms develop to go to  urgent care or emergency room.
Sat AM lump under lt arm (large marble size) gotten worse tender to touch-no redness, or warmth;
Patient?s eyes became swollen and developed welts under them. She then told me her throat itched so intensely, it hurt. We immediately gave her Benadryl and by about 10p, things were subsiding.
Twelve hours after dose: headache, diarrhea, myalgia, cervical lymphadenopathy, nausea, fatigue. Side effects improved by 48 hours after injection and completely resolved by 72 hours after injection.
Information has been received from a physician concerning a 7 year old female, with no medical history and no allergies, who on 26-JUN-2007 was vaccinated once with a 0.5 ml dose of Varivax (Lot# 635207/0075K). There was no concomitant medication. It was noted that the patient had a possible exposure in school to varicella. on 05-SEP-2006 the patient experienced greater than 50 lesions initially appearing on her abdomen which had then spread to her body. The appearance of the rash was an erythematous papular rash progressing to pustules in various stages. No other systemic symptoms were noted. The patient was diagnosed clinically with breakthrough varicella, but was not laboratory confirmed. There were no laboratory or diagnostic tests performed. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. The reporter expressed concern about the lot. A lot check was requested. The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory. The lot let the requirements and was released. Additional information has been requested.
19 year old male with cognitive delay presents with both parents for vaccination. Vaccination received in left deltoid and client had subsequent event with momentary loss of consciousness and muscular rigidity, followed by wakefulness and stated lack of discomfort or dizziness. Vital signs stable; HR 75, BP 117/75, Respirations even and unlabored. Client experienced nausea with emesis of approximately 30 cc after a sip of water. Client declined ER visit. Client monitored for an additional observation period and returned home.
Patient had syncopal episode after receiving vaccine, epinephrine administered via auto injector, patient returned to consciousness. EMS arrived on scene, and walked patient out.
headache; really started aching but he couldn't breathe; really started aching but he couldn't breathe; Chills; allergic reaction after getting the 2nd dose of the vaccine; This is a spontaneous report from a contactable consumer (patient). A 72-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection), via an unspecified route on 23Mar2021 at 12:30, last night or 1:00 (age at vaccination: 72-year-old) as a single dose for covid-19 immunization. Medical history included asthma, allergic to iodine and had covid in Feb2019. The patient concomitant medications were not reported. Past drug history included inhaler (antihistaminic) for 3 times a day for 4 days, when he had Covid in 2019. He said it seems like it was on the cuff of being a threat to his life. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection), via an unspecified route on 02Mar2021 as a single dose for covid-19 immunization. On 23Mar2021, patient experienced an allergic reaction after getting the 2nd dose of the vaccine. He mentioned that he experienced extreme difficulty breathing and he had chills, headache and really started aching but he couldn't breathe. He was wondering if he was going to die but he does not panic when he can't breathe because he has asthma but last night he was concerned. He had to take slow deep breaths through nose to survive it, but it wasn't working, and he wasn't getting enough air, but he fell asleep, and he got through it. He said the pharmacist said that people that who have had Covid have a harder reaction to the shot. He was struggling last night, and it was hard to breathe. He mentioned that his daughter, who is 47, and her family all got Covid infection, and she is having trouble breathing still, she can't even finish a sentence. He was wondering if this was something that ran in the family. He stated he is supposed to keep Benadryl with him, but it knocks him out and he was afraid if he went to sleep, he wouldn't wake up. He asked if this reaction was normal or if it was an allergic reaction. Therapeutic treatment taken as a result of the events included two antihistamines (ChlorTab 4 mg each), two Advil, and 2 shots of his albuterol inhaler and started coming around. The clinical outcome of aches and headache were not as bad and breathing is okay now, outcome of chills and allergic reaction was unknown.   Follow-up (24Mar2021): New information received from a contactable consumer included: dates of 1st and 2nd dose of vaccination added, events added, therapeutic medications updated and medical history updated.  No follow-up attempts are possible; Information about lot/batch number cannot been obtained.
Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Additional Details: Five minutes after vaccination the patient fainted in the restroom. Patient also had symptoms of lightheadedness and sweating. Pt was picked up by family and taken to urgent care as an added precaution to be checked.
After two days I started to get a huge lymph node by my left collar bone. It went away after 10 days but  I have had a bad pain my left shoulder and upper left  chest area since then.
1 of 3 elderly pts presented w/herpes zoster following vax; pt recvd vax & about 2 wks later presented to dermatologist w/pain & erythema; subsequently dx w/shingles & tx w/Pred; pt recovered;
Red raised area 3x3 in circle hot to touch and itchy mom said ice applied.
Fever to 102.0 and headache and mild congestion.  Self medicated with Dayquil relief of fever.  Seen for sick call at Flight Surgeon Office 8/10/2011.